Sunil Healthcare Ltd

Sunil Healthcare Ltd. has submitted its Annual Report for the financial year 2025-26 to the Bombay Stock Exchange and The Calcutta Stock Exchange. The report is being shared in compliance with SEBI (LODR) Regulations, 2015. The company has also announced its 52nd Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 12:30 PM IST via Video Conferencing (VC) / other Audio Visual Means (OAVM). The registered office will be considered the venue for the meeting. The Annual Report, including the Notice of AGM, is being sent to members via email and is also available on the company's website. The report details financial statements, corporate governance, management discussion, and auditor reports.

Sunil Healthcare Ltd has announced the details for its 52nd Annual General Meeting (AGM), scheduled for Monday, September 28, 2026, at 12:30 PM IST. The meeting will be conducted via Video Conferencing (VC)/ other Audio Visual Means (OAVM), with the registered office serving as the deemed venue. M/s. MUFG Intime India Private Limited has been appointed to facilitate remote e-voting and video conferencing. The remote e-voting period will commence on Friday, September 25, 2026, at 9:00 AM and conclude on Sunday, September 27, 2026, at 5:00 PM. The Register of Members and Share Transfer Book will be closed from September 22, 2026, to September 28, 2026, inclusive, for the AGM. Key agenda items include the adoption of audited financial statements for FY26 and the re-appointment of Mr. Sanjay Kumar Kaushik as a Non-Executive Director.

Sunil Healthcare Ltd announced the outcome of its Board Meeting held on August 13, 2026. The Board approved the un-audited financial results for the first quarter of the Financial Year 2026-27, ended June 30, 2026, on a standalone and consolidated basis. Additionally, the company approved the appointment of M/s. MUFG Intime India Private Limited for remote e-voting and video conferencing services for the upcoming 52nd Annual General Meeting (AGM). M/s. ATCS & Associates were appointed as Scrutinizer for the e-voting process. The AGM is scheduled for September 28, 2026, with the book closure period set from September 22 to September 28, 2026. The cut-off date for determining member entitlements for the AGM is September 21, 2026.

Sunil Healthcare Ltd announced the approval of its un-audited financial results for the first quarter of FY 2026-27, ended June 30, 2026. The results were approved for both standalone and consolidated financial statements. The company also announced details regarding its upcoming 52nd Annual General Meeting (AGM), including the appointment of a remote e-voting agency and a scrutinizer. The book closure period for the AGM has been fixed from September 22 to September 28, 2026, with the AGM scheduled for September 21, 2026.

Sunil Healthcare Ltd has announced that its Board of Directors will convene on August 13, 2026. The meeting, to be held via video conference, will primarily focus on considering and approving the Un-Audited Financial Results for the first quarter of FY 2026-27, ended June 30, 2026. These results will be presented on both a standalone and consolidated basis. Additionally, the company confirmed that the trading window, which was closed from July 01, 2026, will remain closed until August 15, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Sunil Healthcare Ltd. has announced a special one-year window, from February 5, 2026, to February 4, 2027, for the transfer and dematerialisation of physical securities. This window is for investors who sold or purchased physical securities before April 1, 2019, and either failed to lodge them for transfer or had them rejected. Transferred securities will be mandatorily dematerialised and subject to a one-year lock-in period. Cases involving disputes or securities transferred to the Investor Education and Protection Fund (IEPF) are excluded. Shareholders are advised to submit necessary documents to the company's Registrar and Share Transfer Agent or the company directly.

Sunil Healthcare Ltd. has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in effect from July 01, 2026, and will remain until 48 hours after the declaration of the company's un-audited financial results for the first quarter of the financial year 2026-27, ending on June 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct to prevent insider trading.

Sunil Healthcare Ltd's board meeting on May 29, 2026, approved the audited financial results (standalone and consolidated) for the year ended March 31, 2026. The board did not recommend any dividend for FY26. M/s. Agrawal S. Lal & Co. were appointed as Internal Auditors for FY27. Consolidated revenue from operations stood at ₹8,771.92 Lakhs for the year ended March 31, 2026.

Sunil Healthcare Ltd. has announced the approval of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board of Directors, in its meeting held on May 29, 2026, also noted the auditor's report with an unmodified opinion and did not recommend any dividend for the financial year 2025-26. Additionally, M/s. Agrawal S. Lal & Co. were appointed as Internal Auditors for the financial year 2026-27.

Sunil Healthcare Ltd approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board did not recommend any dividend for FY26. M/s. Agrawal S. Lal & Co., Chartered Accountants, Alwar, were appointed as Internal Auditors for FY27. Consolidated revenue from operations for the year ended March 31, 2026, stood at ₹8771.92 lakhs.